2010-12-06 00:00:00,Celgene Corporation Announces Updated Clinical Results From REVLIMID Continuous Treatment Phase III Study
2010-12-07 00:00:00,Celgene Celgene International Srl Announces Data From Three Presentations Evaluating Clinical Benefit Of Pomalidomide In Previously Treated Multiple Myeloma
2011-01-05 00:00:00,Celgene Corporation Comments On Long Term Call
2011-01-10 00:00:00,Celgene Corporation Issues FY 2011 EPS Below Reaffirms FY 2010 Revenue Sees FY 2010 EPS At High End Of Prior Guidance
2011-01-27 00:00:00,Celgene Corporation Reaffirms FY 2011 Call
2011-04-28 00:00:00,Celgene Corporation Raises FY 2011Guidance
2011-06-17 00:00:00,FDA Grants Accelerated Approval of Celgene ISTODAX As Treatment for Patients with Peripheral Lymphoma Who Have Received at Least One Prior Therapy
2011-07-28 00:00:00,Celgene Corporation Raises FY 2011 Guidance
2011-10-27 00:00:00,Celgene Corporation Raises FY 2011 Guidance
2011-11-11 00:00:00,Celgene Corporation Revises FY 2011 Revenue Guidance To A Range Above Revises FY 2011 EPS Guidance To A Range Below Call
2011-11-21 00:00:00,Celgene Celgene International Srl Announces Approval for Treatment of Rare Blood Cancer
2011-12-12 00:00:00,Celgene Celgene International Srl Announces Results From Comparative Analysis Of REVLIMID
2011-12-13 00:00:00,Celgene Celgene International Phase II Study Evaluates Clinical Benefit of Pomalidomide in Heavily Patients with Multiple Myeloma
2012-02-09 00:00:00,Celgene Corporation Announces USD15 Million Strategic Equity Investment In Acetylon Pharmaceuticals
2012-04-26 00:00:00,Epizyme Forms Strategic Partnership With Celgene Celgene International Srl
2012-06-13 00:00:00,Celgene Corporation Announces Additional Billion Share Repurchase Program
2012-06-21 00:00:00,Celgene Corporation Reaffirms FY 2012 And FY 2015 Comments On FY 2013 EPS Call
2012-07-26 00:00:00,Celgene Corporation Raises FY 2012 EPS Reaffirms FY 2012 Revenue Guidance
2012-10-02 00:00:00,Celgene ABRAXANE Meets Primary Endpoint Of Survival In Phase III Metastatic Melanoma Study
2012-10-19 00:00:00,Celgene Corporation Trade Flow Review
